Distinct gut and oral microbial profiles differentiate patients with symmetric/asymmetric Parkinson’s disease
Frontiers in Human Neuroscience · 17.03.2026 · 20
DOI: 10.3389/fnhum.2026.1776294 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Human Neuroscience, online erschienen am 17.03.2026. Verfasst von Jia-Ying Jin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Clinical Research Center of Neurological Diseases, The Second Affiliated Hospital of Soochow University, Suzhou, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Parkinson’s disease (PD) presents heterogeneous motor patterns. Symmetric and asymmetric phenotypes potentially reflect distinct pathogenic origins as proposed by the Synuclein Origin and Connectome (SOC) model. However, differences in gut and oral microbiota between these PD subtypes remain unclear.
Objective
To compare gut and oral microbiota characteristics in symmetric and asymmetric PD patients and explore correlations with clinical features.
Methods
Thirty symmetric and twenty-three asymmetric PD patients were enrolled. Fecal and salivary microbiota were analyzed using 16S rRNA sequencing, and clinical features were evaluated using standard motor and non-motor scales.
Results
The symmetric group showed higher H–Y stage and scores of MDS-UPDRS II, DSFS, MMSE, and MoCA than the asymmetric group (all p < 0.05). Gut and oral microbiota structures differed significantly, with higher gut microbial α -diversity in the symmetric group. Desulfobacterota and related taxa were enriched in symmetric PD and correlated positively with GCSI scores, while butyrate-producing bacteria predominated in asymmetric PD. Predicted metabolic analyses indicated enrichment of six pathways in asymmetric gut microbiota and nine pathways enriched in symmetric oral microbiota.
Conclusion
Symmetric and asymmetric PD are associated with distinct clinical and gut microbiota features, including predicted functional profiles. This aligns with the SOC model of divergent disease origins and mechanisms and points to the microbiota as a candidate factor in PD heterogeneity, offering new testable hypotheses for future research.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology and Clinical Research Center of Neurological Diseases, The Second Affiliated Hospital of Soochow University, Suzhou, China.
- Department of Neurology, Suqian First Hospital, Suqian, China.
- Jiangsu Key Laboratory of Drug Discovery and Translational Research for Brain Diseases, Institute of Neuroscience, Soochow University, Suzhou, China.
Zitieren
APA
Jin, J. Y., Li, D., Qian, S., Gao, F., Li, Z. Q., Zhang, J. R., Jin, H., Wang, F., Mao, C. J., Liu, C. F., & Cheng, X. Y. (2026). Distinct gut and oral microbial profiles differentiate patients with symmetric/asymmetric Parkinson’s disease. Frontiers in Human Neuroscience, 20. https://doi.org/10.3389/fnhum.2026.1776294
Vancouver
Jin JY, Li D, Qian S, Gao F, Li ZQ, Zhang JR, et al. Distinct gut and oral microbial profiles differentiate patients with symmetric/asymmetric Parkinson’s disease. Frontiers in Human Neuroscience. 2026;20. doi:10.3389/fnhum.2026.1776294
BibTeX
@article{Jin2026,
author = {Jin, Jia-Ying and Li, Dan and Qian, Shuang and Gao, Fan and Li, Zong-Qin and Zhang, Jin-Ru and Jin, Hong and Wang, Fen and Mao, Cheng-Jie and Liu, Chun-Feng and Cheng, Xiao-Yu},
title = {Distinct gut and oral microbial profiles differentiate patients with symmetric/asymmetric Parkinson’s disease},
journal = {Frontiers in Human Neuroscience},
year = {2026},
volume = {20},
doi = {10.3389/fnhum.2026.1776294}
}
EUVIMED